The full shortlist for the inaugural Global Cardiovascular Awards—which will recognise the tireless work of individuals, teams and organisations to improve the life of sufferers of cardiovascular disease—has now been revealed.
An expert panel of judges has hand-picked finalists and winners across 12 categories, while the Cardiovascular News readership has the opportunity to vote for the winner in the Heart Team of the Year category (see details below). All winners will be announced in-person at an exclusive event in central London on the evening of March 14. Visit globalcardiovascularawards.com to find out how you can attend.
Awards categories touch on the work of clinicians, researchers, healthcare providers, industry, innovators and institutions. Across four industry-led categories, the Global Cardiovascular Awards will honour major advances in technologies and techniques in areas such as interventional cardiology, cardiac surgery, patient and operator safety, as well as cardiac imaging. Categories including Best Cardiovascular Product Launch and CEO of the Year will further recognise industry excellence.
The Digital Innovation Award pays notice to the increasing use of novel digital, mobile or wearable technologies in cardiovascular care, and will crown the best use of digital tools in this space. There are also awards for the best campaigns in education and awareness.
The full list of categories and nominees is as follows:
Innovation in Interventional Cardiology
Endologix – Detour System
Canon Medical Systems – Evolve Technology
Concept Medical – Magic Touch
Radiaction Medical – The Radiaction System
Thubrikar – Optimum TAV
Dot Medical – Pulsecath IVAC
Elixir Medical – Dynamx Drug-Eluting Coronary Bioadaptor Scaffold
GE Healthcare – Prucka 3 │ Cardiolab
Edwards Lifesciences – Evoque Tricuspid Valve
Innovation in Cardiac Surgery
Endologix – Detour System
Christopher Philips – Cryo Nerve Ablation for Sternotomy as a Component of the ERAS Pathway
Fadhil Alamrani – Totally Endoscopic Surgery for Congenital Heart Diseases
Innovation in Patient and Operator Safety
Radiaction Medical – The Radiaction System
Stereotaxis – Robotic Magnetic System
Egg Medical – Eggnest
Innovation in Cardiac Imaging
GE Healthcare – Vscan Air SL
Philips – 3D ICE Catheter Verisight Pro
Canon Medical System – Evolve Technology
Best Cardiovascular Product Launch
Siemens Healthineers – Artis Family
GE Healthcare – Vscan Air SL
Digital Innovation
Dasi Simulations
Egnite – Cardiocare Platform
Elem Biotech – Supercomputer-based In-silico Clinical Cardiac Trials
Essex Cardiothoracic Centre – Remote AF Detection Using Fibricheck
GE Healthcare – Vscan Air SL
CEO of the Year
Teri Sirset – Dasi Simulations
Manish Doshi – Concept Medical
Matt Thompson – Endologix
Best Medical Education Campaign
Medtronic Tour For Life – Mobile Cardiac Surgery Training and Innovation Centre
Philips – AHA National CIED Infection Intitiave
Medtronic EU – TAVI Escape Room
Best Public Awareness Campaign
Global Alliance for Patient Access – Know Your Numbers Treat Your Risk
Heart Valve Voice
Global Heart Hub – Heart Failure Patient Guide
Future Leader
To be announced on 14 March
Clinical Research Excellence
To be announced on 14 March
Lifetime Achievement
To be announced on 14 March
Have your say! Heart Team of the Year
Vote for one of two entries in the Heart Team of the Year Category
CHU de Bordeaux, Bordeaux, France – Medico Surgical Unit of Acquired Cardiac Diseases
The Medico Surgical Unit of Acquired Cardiac Diseases at CHU de Bordeaux is a leader in treatment, education and research in the field of heart valve disease, and the Unit retains a staunch commitment to the treatment of patients using the multidisciplinary heart team approach.
The team are pioneers of new transcatheter approaches for structural heart disease that offer new options for patients, including being among the first in Europe to use the ShortCut device, aimed at preserving coronary access after valve-in-valve transcatheter aortic valve implantation (TAVI), as well as novel solutions in the mitral (including the first-in-man [FIM] transseptal Neochord implant, experience with the Amend annuloplasty, Alta valve, and Intrepid transseptal transcatheter mitral valve replacement [TMVR] system), tricuspid (Lux valve) and aortic valves.
The team leads several international studies exploring various options to treat valvular diseases as well as research and development projects in the field including heart valve imaging. The team is delivering research to create the first complete image guidance solution based on artificial intelligence (AI) for clinical decision-making to improve the adoption, patient selection and outcomes of transcatheter procedures.
The team gathers cardiac surgeons, interventional and imaging cardiologists in the same unit, who work together to decide on the best treatment options for the patient, including surgical or transcatheter approaches, avoiding any selection bias.
James Cook University Hospital (JCUH), Middlesbrough, UK – Cardiothoracic Team
The Cardiovascular Unit at the James Cook University Hospital (JCUH) in Middlesbrough was only founded 30 years ago but their team of cardiologists and surgeons are recognised as world leaders in the treatment and research of cardiovascular disease, particularly with regards to the management of patients with heart valve disease.
The JCUH TAVI (transcatheter aortic valve implantation) team have pioneered many developments in the UK including the creation of the specialist nurse role to manage the TAVI patient pathway, single point-of-access referral for all patients with valve disease and percutaneous axillary access for TAVI (as an alternative to the standard femoral access).
Through continuous service optimisation the duration of stay for TAVI patients at JCUH has progressively fallen and is the shortest in the UK with an average hospital stay of just one day. As an extension to this, the team introduced a same day discharge programme for TAVI in 2018, allowing patients to be treated with no overnight stay in hospital. This was the first such programme in the world.
The benefits of a streamlined TAVI pathway were clearly demonstrated in 2023 when the JCUH TAVI team set a record of 10 successful TAVI procedures in one day, with seven patients receiving their new heart valve being admitted and returning home the same day.
The James Cook University Hospital has been recognised as an international Benchmark centre for TAVI and their consultants and specialist nurses proctor and educate other centres in the UK and Europe on optimisation of TAVI pathways. The valve pathways and TAVI service at JCUH were highlighted as exemplars for best practice in NHS Getting It Right First Time (GIRFT) guidance, distributed to all UK cardiac centres in 2023. It is expected that the service developments pioneered at JCUH will promote standardisation of TAVI pathways throughout the UK—resulting in better clinical outcomes, better patient experience and reduced NHS costs.
